Literature DB >> 21561671

Anxiety, depression and quality of life (QoL) in patients with chronic dizziness.

Yuan-Yang Cheng1, Chia-Hua Kuo, Wan-Ling Hsieh, Shin-Da Lee, Wei-Ju Lee, Liang-Kung Chen, Chung-Lan Kao.   

Abstract

Mood disorders and the severity of dizziness often interact with each other. However, the impact of age on anxiety and depression in dizzy patients has rarely been explored. The purpose of this study was to evaluate the correlation between the Dizziness Handicap Inventory (DHI) and the Hospital Anxiety and Depression Scale (HADS) in a group of patients with dizziness. The statistical relationships between age and each scale were studied. This cross-sectional study revealed a high correlation between DHI subgroups and HADS subscales. We found statistical correlation between neither age and HADS subscales nor age and DHI subgroups. In addition, Short-Form 36 Health Survey Questionnaires (SF-36) showed a high correlation with the dizziness handicap severity. The present study revealed that age does not influence mood disorders and the severity of dizziness in dizzy patients.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21561671     DOI: 10.1016/j.archger.2011.04.007

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  9 in total

1.  Quality of Life Rating for Dizziness: A Self-reporting Questionnaire.

Authors:  Rajesh Ranjan; Jayashree Bhat; Priyanka E M Vas Naik
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-02-02

2.  Efficacy and safety of acupuncture for dizziness and vertigo in emergency department: a pilot cohort study.

Authors:  Chih-Wen Chiu; Tsung-Chieh Lee; Po-Chi Hsu; Chia-Yun Chen; Shun-Chang Chang; John Y Chiang; Lun-Chien Lo
Journal:  BMC Complement Altern Med       Date:  2015-06-09       Impact factor: 3.659

3.  Efficacy and safety of acupuncture for chronic dizziness: study protocol for a randomized controlled trial.

Authors:  Zhe Xue; Cun-Zhi Liu; Guang-Xia Shi; Yan Liu; Zhao-Xin Li; Zhen-Hua Zhang; Lin-Peng Wang
Journal:  Trials       Date:  2013-12-13       Impact factor: 2.279

4.  Role of Emotional Distress in Prolongation of Dizziness: A Cross-Sectional Study.

Authors:  Kyung Jin Roh; Min Ki Kim; Ji Hyung Kim; Eun Jin Son
Journal:  J Audiol Otol       Date:  2017-12-29

5.  Relation of anxiety and other psychometric measures, balance deficits, impaired quality of life, and perceived state of health to dizziness handicap inventory scores for patients with dizziness.

Authors:  D A Schmid; J H J Allum; M Sleptsova; A Welge-Lüssen; R Schaefert; G Meinlschmidt; W Langewitz
Journal:  Health Qual Life Outcomes       Date:  2020-06-26       Impact factor: 3.186

6.  A retrospective analysis of two tertiary care dizziness clinics: a multidisciplinary chronic dizziness clinic and an acute dizziness clinic.

Authors:  Phillip Staibano; Daniel Lelli; Darren Tse
Journal:  J Otolaryngol Head Neck Surg       Date:  2019-03-11

7.  The Relationship between Extrinsic and Intrinsic Religious Orientation with Perceived Stress and Cigarette Addiction among University Students.

Authors:  Nabi Banazadeh; Abdolreza Sabahi; Hasan Ziaadini; Arash Jalali-Khalilabadi; Mohammad Banazadeh
Journal:  Addict Health       Date:  2019-04

8.  Benign paroxysmal positional vertigo, dizziness, and health-related quality of life among older adults in a population-based setting.

Authors:  Ingmar Skoog; Caterina Finizia; Ellen Lindell; Lena Kollén; Mia Johansson; Therese Karlsson; Lina Rydén; Hanna Falk Erhag; Hanna Wetterberg; Anna Zettergren
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-19       Impact factor: 2.503

9.  Self-Reported Measures Have a Stronger Association With Dizziness-Related Handicap Compared With Physical Tests in Persons With Persistent Dizziness.

Authors:  Lene Kristiansen; Liv H Magnussen; Kjersti T Wilhelmsen; Silje Maeland; Stein Helge G Nordahl; Anders Hovland; Richard Clendaniel; Eleanor Boyle; Birgit Juul-Kristensen
Journal:  Front Neurol       Date:  2022-07-15       Impact factor: 4.086

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.